Literature DB >> 11349739

Fatal disseminated adenoviral infection in a renal transplant patient.

H Ardehali1, K Volmar, C Roberts, M Forman, L C Becker.   

Abstract

Immunosuppressed patients are more susceptible to adenoviral infection and carry a significantly higher mortality than immunocompetent patients. Renal transplant patients with adenoviral infection most often present with infection of the kidney and urinary tract within weeks to months of transplant surgery, suggesting reactivation of the latent adenovirus in the immunosuppressed host as the source of infection. We describe the first case of a fatal adenovirus infection after several years of immunosuppression in a kidney transplant patient. Postmortem examination of several tissues, using standard viral culture and polymerase chain reaction, was positive for adenovirus serotype 21. This case is unusual in that the fatal disseminated viral infection occurred after 6 years of immunosuppression, suggesting that the source of adenovirus was a novel infection rather than reactivation of latent infection, or infection from the transplanted tissue. Furthermore, this is the first report of adenovirus type 21 in an immunosuppressed patient.

Entities:  

Mesh:

Year:  2001        PMID: 11349739     DOI: 10.1097/00007890-200104150-00029

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

1.  Coagulation factor X activates innate immunity to human species C adenovirus.

Authors:  Konstantin Doronin; Justin W Flatt; Nelson C Di Paolo; Reeti Khare; Oleksandr Kalyuzhniy; Mauro Acchione; John P Sumida; Umeharu Ohto; Toshiyuki Shimizu; Sachiko Akashi-Takamura; Kensuke Miyake; James W MacDonald; Theo K Bammler; Richard P Beyer; Frederico M Farin; Phoebe L Stewart; Dmitry M Shayakhmetov
Journal:  Science       Date:  2012-09-27       Impact factor: 47.728

2.  Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-cell chronic lymphocytic leukemia.

Authors:  Nina Cavalli-Björkman; Eva Osby; Jeanette Lundin; Mats Kalin; Anders Osterborg; Astrid Gruber
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

3.  Effects of immunosuppression on circulating adeno-associated virus capsid-specific T cells in humans.

Authors:  Elizabeth M Parzych; Hua Li; Xiangfan Yin; Qin Liu; Te-Lang Wu; Gregory M Podsakoff; Katherine A High; Matthew H Levine; Hildegund C J Ertl
Journal:  Hum Gene Ther       Date:  2013-04       Impact factor: 5.695

4.  Adenovirus diseases: a systematic review and meta-analysis of 228 case reports.

Authors:  Jie Gu; Qing-Qing Su; Ting-Ting Zuo; Yan-Bin Chen
Journal:  Infection       Date:  2020-07-27       Impact factor: 7.455

5.  Life-threatening adenovirus infection in a kidney transplant recipient.

Authors:  Katherine Barraclough; Kimberley Oliver; Elliot Geoffrey Playford; John Preston; Scott Campbell; David W Johnson; Carmel Hawley; David Mudge; Carolyn van Eps; Nicole Isbel
Journal:  NDT Plus       Date:  2009-02-09

6.  IL-1α and complement cooperate in triggering local neutrophilic inflammation in response to adenovirus and eliminating virus-containing cells.

Authors:  Nelson C Di Paolo; Lisa K Baldwin; Eric E Irons; Thalia Papayannopoulou; Stephen Tomlinson; Dmitry M Shayakhmetov
Journal:  PLoS Pathog       Date:  2014-03-20       Impact factor: 6.823

7.  Clinical Features and Radiological Findings of Adenovirus Pneumonia Associated with Progression to Acute Respiratory Distress Syndrome: A Single Center Study in 19 Adult Patients.

Authors:  Min Jae Cha; Myung Jin Chung; Kyung Soo Lee; Tae Jung Kim; Tae Sung Kim; Semin Chong; Jungho Han
Journal:  Korean J Radiol       Date:  2016-10-31       Impact factor: 3.500

Review 8.  Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention.

Authors:  Joseph P Lynch; Adriana E Kajon
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

9.  Disseminated Adenovirus Nephritis After Kidney Transplantation.

Authors:  Timothy Hatlen; Henry Mroch; Katherine Tuttle; Okechukwu Ojogho; Michele Rooney; Sara Desmond; Samer Bani-Hani
Journal:  Kidney Int Rep       Date:  2017-08-12

10.  Exposure to wild-type AAV drives distinct capsid immunity profiles in humans.

Authors:  Klaudia Kuranda; Priscilla Jean-Alphonse; Christian Leborgne; Romain Hardet; Fanny Collaud; Solenne Marmier; Helena Costa Verdera; Giuseppe Ronzitti; Philippe Veron; Federico Mingozzi
Journal:  J Clin Invest       Date:  2018-10-22       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.